Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Gains from Investment Securities (2019 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Gains from Investment Securities for 7 consecutive years, with $2.1 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 6.6% to $2.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.8 million through Dec 2025, up 55.87% year-over-year, with the annual reading at $7.9 million for FY2025, 9.85% up from the prior year.
  • Gains from Investment Securities hit $2.1 million in Q4 2025 for Harmony Biosciences Holdings, up from $1.4 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $7.5 million in Q2 2024 to a low of $30835.0 in Q1 2025.
  • Historically, Gains from Investment Securities has averaged $2.2 million across 5 years, with a median of $1.3 million in 2025.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 12155.0% in 2022 and later tumbled 94.59% in 2023.
  • Year by year, Gains from Investment Securities stood at $2.0 million in 2021, then surged by 50.23% to $2.9 million in 2022, then skyrocketed by 112.83% to $6.3 million in 2023, then tumbled by 64.43% to $2.2 million in 2024, then dropped by 6.6% to $2.1 million in 2025.
  • Business Quant data shows Gains from Investment Securities for HRMY at $2.1 million in Q4 2025, $1.4 million in Q3 2025, and $1.3 million in Q2 2025.